Jalen Hurts’ move to injured reserve has transformed a carefully managed medical concern into a major disruption for Philadelphia, forcing the Eagles to reshuffle their quarterback depth while leaving questions about how quickly the injury escalated.

The Eagles said Hurts suffered the injury after taking a cleat to his calf during the team’s Oct. 4 game against the Los Angeles Rams. After he reported the problem following practice, doctors discovered a superficial blood clot during an ultrasound in London. The team initially determined that playing was safe because “activity and mobility were important,” while also recommending follow-up testing.¹

That decision now looks more consequential. Hurts was ruled out for the upcoming game against Carolina and placed on injured reserve two days later. Tanner McKee is set to start, and Philadelphia is adding Joe Milton for depth—moves that suggest the Eagles are preparing for uncertainty rather than treating the issue as a short-term absence.

The medical perspective is cautious but not alarmist: the Eagles’ statement emphasized that Hurts could safely play at the time of the original evaluation, while the later injured-reserve designation reflects updated risk management. The central tension is between maintaining mobility, as doctors advised, and limiting exposure once a blood clot was identified.

The supplied conservative article offers no competing interpretation of Hurts’ condition. Instead, it concerns the Indianapolis Colts, where coach Shane Steichen defended Daniel Jones despite mounting losses and boos from fans. Steichen acknowledged, “I got to coach better,” and said he did not blame supporters for booing.² That contrast matters: Philadelphia’s story is about medical uncertainty and contingency planning; Indianapolis’ is about performance, accountability and job security. Conflating them would obscure the distinct pressures facing each team.